Metformin Regulating miR-34a Pathway to Inhibit Egr1 in Rat Mesangial Cells Cultured with High Glucose
Background. Activating AMPKα negatively regulates Egr1 to inhibit inflammatory cytokines in high glucose. miR-34a inhibition increases phosphorylated AMPKα through mediating SIRT1 to suppress the development of fatty liver. Aim of the Study. To clarify the function of Egr1 on the inflammation and fi...
Saved in:
Main Authors: | Can Wu, Ningning Qin, Huiwen Ren, Min Yang, Shuang Liu, Qiuyue Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2018/6462793 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Associations of miR-499 and miR-34b/c Polymorphisms with Susceptibility to Hepatocellular Carcinoma: An Evidence-Based Evaluation
by: Zhongxia Wang, et al.
Published: (2013-01-01) -
Altered Expressions of miR-1238-3p, miR-494, miR-6069, and miR-139-3p in the Formation of Chronic Brucellosis
by: Ferah Budak, et al.
Published: (2016-01-01) -
miR-126 and miR-126*: New Players in Cancer
by: Jeannette Meister, et al.
Published: (2010-01-01) -
Interactions of miR-34b/c and TP53 Polymorphisms on the Risk of Intracranial Aneurysm
by: Lijuan Li, et al.
Published: (2012-01-01) -
Liraglutide Regulates the Kidney and Liver in Diabetic Nephropathy Rats through the miR-34a/SIRT1 Pathway
by: Shan Xiao, et al.
Published: (2021-01-01)